C
Cathay Biotech Inc
SSE:688065
Cathay Biotech Inc
SSE:688065
Price:
55.5
CNY
3.49%
Market Closed
Market Cap:
¥40B
Relative Value
The Relative Value of one Cathay Biotech Inc stock under the Base Case scenario is 23.05 CNY. Compared to the current market price of 55.5 CNY, Cathay Biotech Inc is Overvalued by 58%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
23.05
CNY
Overvaluation 58%
C
Multiples Across Competitors
Competitors Multiples
Cathay Biotech Inc Competitors
Cathay Biotech Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Cathay Biotech Inc
SSE:688065
|
40B CNY | 12.2 | 67.3 | 67.2 | 67.2 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
89B USD | 3.8 | 34.8 | 22.4 | 26.2 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
80.2B USD | 5 | 40.3 | 22.9 | 30.7 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
9.8T JPY | 3.8 | 20.1 | 9.6 | 13.3 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
262.9B CNY | 1.5 | 23.7 | 20.5 | 20.5 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
27.6B CHF | 3.7 | 25.5 | 17.4 | 21.9 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
26.9B USD | 1.9 | 27.1 | 12.1 | 14.9 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.3 | 54.8 | 28.9 | 37.9 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 6.8 | 61.2 | 36.6 | 45 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.3 | 11.9 | 8.7 | 10.9 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
17.7B EUR | 1.4 | 72.2 | 9.9 | 35.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
